Defibrillators Market Size & Share 2026-2035

Defibrillators Market Size

The global defibrillators market was valued at USD 14.9 billion in 2025. The market is expected to reach from USD 16.2 billion in 2026 to USD 26.2 billion in 2035, growing at a CAGR of 5.5% during the forecast period, according to the latest report published by Global Market Insights Inc.

The high market growth is attributed to the rising prevalence of cardiovascular diseases, increasing incidence of sudden cardiac arrest, growing geriatric population, and technological advancements in defibrillation devices, among other contributing factors. Defibrillators are medical devices that deliver a controlled electrical shock to the heart to restore a normal rhythm during life-threatening arrhythmias such as ventricular fibrillation or sudden cardiac arrest. They are used in hospitals, emergency settings, public access locations, and implantable cardiac therapies to stabilize heart function and prevent cardiac death.
 

The major players in the global defibrillators market are Medtronic, Boston Scientific, Abbott, Philips, and Stryker. These companies maintain their competitive position through ongoing product innovation, global market presence, and substantial investment in research and development.
 

The market has increased from USD 11.2 billion in 2022 and reached to USD 13.6 billion in 2024, with a historic growth rate of 10%. The market growth was driven by the expanding emergency medical infrastructure, rising government initiatives for public access defibrillation programs, increasing healthcare expenditure, and growing awareness regarding early cardiac arrest response.
 

Moreover, as populations age worldwide and lifestyles become more sedentary, unhealthy diets are leading to a rise in cardiovascular diseases. For instance, according to the World Health Organization (WHO), cardiovascular diseases accounted for approximately 17.9 million deaths globally in 2022, representing 32% of all global deaths. These include conditions like arrhythmias, ventricular fibrillation, and sudden cardiac arrest (SCA). In such emergencies, defibrillators are crucial for restoring normal heart rhythms.
 

Additionally, the American Heart Association reported that over 356,000 out-of-hospital cardiac arrests occurred annually in the U.S. as of 2023, with a survival rate of less than 12%. Given the increasing number of patients at risk for SCA, hospitals and emergency medical services are ramping up their adoption of defibrillators.
 

Furthermore, manufacturers are developing advanced defibrillators with features such as wireless connectivity, real-time patient monitoring, automated shock delivery, and integration with emergency response systems. Portable and user-friendly AEDs with voice instructions are making devices accessible even to untrained bystanders. These innovations improve treatment outcomes and expand the use of defibrillators beyond hospitals.

Defibrillators Market Trends

Several trends are currently shaping the defibrillator market. The adoption of wearable defibrillators, which continuously monitor patients at risk of sudden cardiac arrest and deliver immediate treatment, is growing significantly. These wearable medical devices offer patients greater mobility and a sense of security, especially for those waiting for implantable defibrillator surgeries.
 

• Additionally, the integration of smart technology in defibrillators, such as Bluetooth-enabled data sharing and cloud connectivity, is driving innovation. Such features allow healthcare providers to remotely monitor device performance and patients cardiac health in real time, enhancing patient care and adherence to follow-ups. Also, increased emphasis on public access defibrillation (PAD) programs in schools, airports, and public transport stations is another key trend, aimed at providing timely response in cases of out-of-hospital cardiac arrests.
   
• In regions with ageing populations, particularly in Europe and North America, there is a growing awareness about the benefits of home-use defibrillators, which is contributing to increased demand. Together, these trends are expected to drive innovation and accessibility in the defibrillator market.
   

Defibrillators Market Analysis

Based on product, the defibrillators market is segmented into implantable cardioverter defibrillator (ICD) and external cardioverter defibrillator. The implantable cardioverter defibrillator (ICD) segment has asserted its dominance in the market by securing a significant market share of 71.3% in 2025 owing to the increasing clinical adoption for long-term management of life-threatening arrhythmias, rising prevalence of sudden cardiac arrest, and strong physician preference for implantable solutions in high-risk cardiac patients. The segment is expected to exceed USD 18.4 billion by 2035, growing at a CAGR of 5.3% during the forecast period.
 

• The growing incidence of ventricular tachycardia and ventricular fibrillation is a major factor driving the adoption of implantable cardioverter defibrillators (ICDs). These conditions significantly increase the risk of sudden cardiac arrest, requiring continuous monitoring and rapid therapeutic intervention. ICDs automatically detect abnormal rhythms and deliver shocks to restore normal heart function, making them a critical treatment option.
   
• Continuous innovations such as MRI-compatible ICDs, longer battery life, smaller device sizes, and improved lead designs are enhancing device safety and performance. Additionally, the development of subcutaneous ICDs reduces complications associated with traditional transvenous leads. These advancements are encouraging physicians and patients to adopt ICD therapy.
   
• The external cardioverter defibrillator segment held a revenue of USD 4.3 billion in 2025, with projections indicating a steady expansion at a CAGR of 5.9% from 2026 to 2035. The segment is driven by the growing installation of automated external defibrillators (AEDs) in public places such as airports, schools, and workplaces, along with increasing government initiatives promoting public access defibrillation programs. Additionally, rising awareness of sudden cardiac arrest response and the demand for portable emergency cardiac care devices are supporting segment growth.
   

Based on end use, the defibrillators market is classified into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 67.8% in 2025 and is expected to reach USD 18 billion within the forecast period.
 

• As critical care centers, hospitals are equipped with advanced defibrillator devices, including both ICDs and AEDs, to address life-threatening cardiac conditions. The availability of skilled healthcare professionals who can effectively operate defibrillators in emergencies further positions hospitals as primary end-users in this market.
   
• Additionally, hospitals frequently serve patients with complex heart conditions who require continuous cardiac arrythmia monitoring, increasing the need for advanced defibrillation solutions to manage and prevent cardiac arrest events. Furthermore, initiatives to incorporate digital health technologies in hospitals enable remote monitoring and timely alerts for high-risk patients, making hospitals a central distribution point for defibrillators and reinforcing their significant market share.   
   
• The ambulatory surgical centers segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 5.1% over the forecast period. The segment's growth is driven by the increasing number of outpatient surgical procedures and the need for immediate cardiac emergency management during minimally invasive surgeries. Additionally, ASCs are increasingly adopting compact external defibrillators to enhance patient safety and comply with emergency care regulations.
   

North America Defibrillators Market

North America dominated the global market with the highest market share of 37.3% in 2025.
 

• The U.S. market was valued at USD 4 billion and USD 4.4 billion in 2022 and 2023, respectively. The market size reached USD 5.2 billion in 2025, growing from USD 4.8 billion in 2024, and is anticipated to grow at a CAGR of 4.5% from 2026 to 2035.
   
• North America has one of the highest incidences of cardiovascular diseases and sudden cardiac arrest globally. Sedentary lifestyles, obesity, hypertension, and diabetes contribute significantly to cardiac risk factors. Numerous cardiac arrest cases occur outside hospital settings, increasing the demand for automated external defibrillators (AEDs) and implantable cardioverter defibrillators (ICDs). This high disease burden strongly supports consistent demand for advanced defibrillation devices.
   
• The region hosts several major defibrillator manufacturers that actively invest in research, innovation, and product commercialization. Continuous product launches, technological advancements, and strategic collaborations with healthcare providers improve device accessibility. The presence of well-established distribution networks further ensures rapid market penetration. Such industry leadership significantly accelerates regional adoption of defibrillator technologies.
   

Europe Defibrillators Market

Europe market accounted for USD 4.2 billion in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• Several European countries have implemented national programs to expand the availability of AEDs in public spaces. Governments and local municipalities are installing defibrillators in transportation hubs, stadiums, and government facilities. Public awareness campaigns and mandatory CPR training initiatives further promote their use. These efforts are significantly increasing the installed base of defibrillators across the region.
   
• Most European countries have well-established healthcare systems with universal coverage. Access to specialized cardiac care and electrophysiology procedures enables patients to receive advanced therapies such as ICD implantation. Hospitals are equipped with modern diagnostic and emergency treatment technologies. This robust healthcare infrastructure supports widespread adoption of defibrillators.
   

Asia Pacific Defibrillators Market

The Asia Pacific market is anticipated to grow at the highest CAGR of 7.2% during the analysis timeframe.
 

• Many governments in the region are investing heavily in healthcare infrastructure, including new hospitals and specialized cardiac care centers. Improvements in medical facilities and diagnostic capabilities are enabling the treatment of complex cardiac conditions. The expansion of cardiac catheterization labs and electrophysiology centers is facilitating greater use of defibrillators.
   
• Economic growth in many Asia Pacific countries has led to higher healthcare spending by both governments and private healthcare providers. Private hospitals are increasingly investing in advanced cardiac devices to enhance treatment capabilities. This financial growth enables wider adoption of implantable defibrillators and emergency response equipment.
   

Latin America Defibrillators Market

The Latin America market is experiencing robust growth over the analysis timeframe.
 

• The private healthcare sector in Latin America has grown significantly in recent years. Private hospitals and specialty cardiac centers are investing in advanced medical equipment to attract patients seeking high-quality care. This includes the adoption of implantable cardioverter defibrillators and modern emergency defibrillation systems.
   
• Several countries in the region are strengthening emergency medical response systems and ambulance networks. First responders are being equipped with portable defibrillators to manage cardiac emergencies outside hospital settings. Improved pre-hospital care infrastructure is increasing the deployment of defibrillation technologies.
   

Middle East & Africa Defibrillators Market

The Middle East & Africa (MEA) market is experiencing robust growth over the analysis timeframe.
 

• Countries in the Middle East are experiencing a sharp rise in lifestyle-related diseases such as obesity, diabetes, and hypertension. These conditions significantly increase the risk of cardiac arrhythmias and sudden cardiac arrest. As a result, healthcare providers are increasingly adopting advanced cardiac monitoring and defibrillation technologies.
   
• Gulf Cooperation Council (GCC) countries are heavily investing in healthcare infrastructure to build advanced medical facilities. New hospitals, cardiac centers, and specialized treatment facilities are being established across the region. These investments are enabling wider availability of advanced devices such as implantable and external defibrillators.
   

Defibrillators Market Share

The global market is characterized by strong competition among global medical device manufacturers, driven by continuous innovation, strategic partnerships, and expanding product portfolios. Companies are focusing on developing technologically advanced defibrillation devices with improved battery life, remote monitoring capabilities, and enhanced patient safety features. The market includes both implantable and external defibrillators, with players competing through product differentiation, regulatory approvals, and expansion into emerging healthcare markets.
 

Key players include Medtronic, Boston Scientific, Abbott, Philips, and Stryker, collectively accounting for ~68% of the total market share. These companies maintain strong global distribution networks and invest significantly in research and development to enhance device performance and reliability. Strategic initiatives such as mergers and acquisitions, product launches, and collaborations with healthcare institutions further strengthen their competitive positioning in the market.
 

In addition to major players, several regional and specialized manufacturers contribute to market competition by offering cost-effective defibrillation solutions and targeting niche segments such as portable AEDs and wearable defibrillators. Increasing regulatory approvals and growing healthcare infrastructure in emerging economies are also encouraging new entrants to participate in the market. As demand for advanced cardiac care rises globally, competition is expected to intensify with a continued focus on innovation, accessibility, and integrated digital health capabilities.
 

Defibrillators Market Companies

A few of the prominent players operating in the defibrillators industry include:

• Abbott
• Amiitalia
• Asahi KASEI
• BIOTRONIK
• Boston Scientific
• BPL Medical Technologies
• CU MEDICAL
• MEDITECH
• Medtronic
• MicroPort
• Mindray
• NIHON KOHDEN
• Philips
• SCHILLER
• Stryker
   
• Medtronic

Medtronic holds a strong leadership position in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds), supported by a broad cardiac rhythm management portfolio. The company’s advanced remote monitoring platforms and long-lasting device technologies enhance patient management and clinical outcomes.
 

• Boston Scientific

Boston Scientific differentiates itself through its subcutaneous implantable cardioverter defibrillator (S-ICD) technology that eliminates the need for transvenous leads, reducing infection and lead-related complications. Its focus on minimally invasive cardiac rhythm solutions and integrated diagnostic capabilities strengthens physician adoption.
 

• Abbott

It offers a comprehensive electrophysiology and cardiac rhythm management ecosystem, integrating ICDs with advanced cardiac mapping and remote monitoring technologies. The company’s devices emphasize MRI compatibility, improved battery longevity, and seamless digital connectivity for long-term patient monitoring.
 

Defibrillators Industry News

• In January 2026, Abbott announced a collaboration with AtaCor Medical to develop a next-generation investigational extravascular implantable cardioverter defibrillator (EV-ICD) system aimed at treating patients with life-threatening heart rhythm disorders. The partnership combined AtaCor’s investigational parasternal EV-ICD lead (Atala) with Abbott’s ICD technology to advance safer defibrillation solutions. This development is expected to support innovation in defibrillator technologies and contribute to the market growth by promoting next-generation, less invasive cardiac rhythm management devices.
   
• In September 2025, ZOLL, an Asahi Kasei company, announced that its Zenix professional monitor/defibrillator received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA). The device was designed to improve efficiency, clarity, and workflow automation in both emergency medical services (EMS) and hospital settings. This approval anticipated to strengthen technological advancements in defibrillator systems and support market growth by expanding the availability of advanced monitoring and defibrillation solutions.
   
• In May 2024, Defibtech announced an expansion of its Lifeline VIEW and ECG defibrillator product lines within the U.S. This expansion aims to make these advanced, user-friendly defibrillators more widely available to support both public and professional use. The Lifeline VIEW defibrillators feature easy-to-follow video instructions, enhancing accessibility during emergency situations.  
   
• In October 2023, Medtronic received FDA approval for its Extravascular Implantable Cardioverter Defibrillator (EV ICD) system, a groundbreaking device designed to treat abnormal heart rhythms and prevent sudden cardiac arrest. Unlike traditional ICDs, the EV ICD places the lead outside the heart and veins, reducing potential complications associated with transvenous leads. This new device combines the benefits of an implantable defibrillator with minimized surgical invasiveness, offering a novel option for patients needing defibrillation therapy.
   

The defibrillators market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Implantable cardioverter defibrillator (ICD)
  • Transvenous implantable cardioverter defibrillator
    • Dual-chamber ICDs
    • Single-chamber ICDs
  • Subcutaneous implantable cardioverter defibrillator
• External cardioverter defibrillator
  • Manual ED
  • Automated ED
    • Semi-automated external defibrillator
    • Fully automated external defibrillator
  • Wearable cardioverter defibrillator

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE